Klaria reports last subject dosed in Sumtariptan Alginate Film study
Klaria reports that the last subject has been dosed in the pivotal Sumatriptan Alginate Film bioequivelance study. The first subject was dosed in December of 2020 and a total of approximately 60 individuals have been included in the study.The current bioequivalence study of Klaria’s Sumatriptan Alginate Film (KL-00119) has concluded the ‘in life’ phase in which blood plasma levels of sumatriptan were assessed in study participants after taking either Klaria’s Sumatriptan Alginate Film or the chosen comparator products. In the coming weeks, detailed statistical analysis of the data will be